184 related articles for article (PubMed ID: 34942430)
1. Effect of postmastectomy radiotherapy on pT
Guo XY; Sun GY; Wang HM; Liu M; Zhang YJ; Zhang N; Tang Y; Zhao XR; Jing H; Fang H; Wen G; Guo QS; Wu HF; Wang XH; Ma CY; Li YX; Cheng J; Shi M; Wang SL
Breast; 2022 Feb; 61():108-117. PubMed ID: 34942430
[TBL] [Abstract][Full Text] [Related]
2. Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.
Tseng YD; Uno H; Hughes ME; Niland JC; Wong YN; Theriault R; Blitzblau RC; Moy B; Breslin T; Edge SB; Hassett MJ; Punglia RS
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):622-30. PubMed ID: 26461004
[TBL] [Abstract][Full Text] [Related]
3. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
4. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
5. Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients.
Wang J; Luo J; Jin K; Wang X; Yang Z; Ma J; Mei X; Wang X; Zhou Z; Yu X; Chen X; Guo X
Cancer Med; 2020 Apr; 9(7):2427-2434. PubMed ID: 32048817
[TBL] [Abstract][Full Text] [Related]
6. Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer.
Zhao XR; Tang Y; Wu HF; Guo QS; Zhang YJ; Shi M; Cheng J; Wang HM; Liu M; Ma CY; Wen G; Wang XH; Fang H; Jing H; Song YW; Jin J; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Zhang N; Li YX; Wang SL
Breast; 2022 Dec; 66():136-144. PubMed ID: 36270084
[TBL] [Abstract][Full Text] [Related]
7. Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy.
Muhsen S; Moo TA; Patil S; Stempel M; Powell S; Morrow M; El-Tamer M
Ann Surg Oncol; 2018 Jul; 25(7):1912-1920. PubMed ID: 29564588
[TBL] [Abstract][Full Text] [Related]
8. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
9. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
Front Oncol; 2022; 12():789198. PubMed ID: 35280719
[TBL] [Abstract][Full Text] [Related]
10. Postmastectomy radiotherapy benefit in Chinese breast cancer patients with T1-T2 tumor and 1-3 positive axillary lymph nodes by molecular subtypes: an analysis of 1369 cases.
Shen H; Zhao L; Wang L; Liu X; Liu X; Liu J; Niu F; Lv S; Niu Y
Tumour Biol; 2016 May; 37(5):6465-75. PubMed ID: 26631044
[TBL] [Abstract][Full Text] [Related]
11. Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes.
Moo TA; McMillan R; Lee M; Stempel M; Ho A; Patil S; El-Tamer M
Ann Surg Oncol; 2014 May; 21(5):1569-74. PubMed ID: 24488216
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy.
Selz J; Stevens D; Jouanneau L; Labib A; Le Scodan R
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1123-32. PubMed ID: 22572073
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of postoperative radiotherapy in patients with breast cancer and with pT1-2 and 1-3 lymph node metastases: A retrospective cohort study based on the Japanese Breast Cancer Registry.
Yamada A; Hayashi N; Kumamaru H; Nagahashi M; Usune S; Asaga S; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Ogo E; Tamura K; Tanakura K; Tada K; Niikura N; Yoshida M; Ohno S; Ishikawa T; Narui K; Endo I; Imoto S; Jinno H
Eur J Cancer; 2022 Sep; 172():31-40. PubMed ID: 35752154
[TBL] [Abstract][Full Text] [Related]
14. Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
Jwa E; Shin KH; Lim HW; Jung SY; Lee S; Kang HS; Lee E; Park YH
PLoS One; 2015; 10(12):e0145463. PubMed ID: 26691445
[TBL] [Abstract][Full Text] [Related]
15. Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy.
Lai SF; Chen YH; Kuo WH; Lien HC; Wang MY; Lu YS; Lo C; Kuo SH; Cheng AL; Huang CS
Ann Surg Oncol; 2016 Nov; 23(12):3860-3869. PubMed ID: 27436202
[TBL] [Abstract][Full Text] [Related]
16. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
[TBL] [Abstract][Full Text] [Related]
17. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype.
Ma JC; Zhong XR; Luo T; Xiang ZZ; Li JY; Luo C; Yan X; He P; Tian TL; Liu F; Liu L; Zheng H
Ann Surg Oncol; 2021 Sep; 28(9):5084-5095. PubMed ID: 33580420
[TBL] [Abstract][Full Text] [Related]
19. Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
Wang X; Zhang L; Zhang X; Luo J; Wang X; Chen X; Yang Z; Mei X; Yu X; Zhang Z; Guo X; Shao Z; Ma J
Breast Cancer Res Treat; 2021 Nov; 190(2):277-286. PubMed ID: 34490502
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
